EVALUATE THE CONCENTRATION OF SERUM CFDNA AND INTEGRITY AS A NON-INVASIVE MARKER TO DISTINGUISH BETWEEN MALIGNANT AND BENIGN BREAST LESION. (2024). Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, 31(1), 366-389. https://jrdiabet.ro/index.php/RJDNMD/article/view/304